It further said that the single-dose ampules are both bioequivalent and therapeutically equivalent to the reference listed ...

Glenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets.

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.

According to IQVIATM sales data for the 12-month period ending November 2024, the Vitamin K1 Injectable Emulsion USP, 10 mg/mL market 2 achieved annual sales of approximately $19.7 million*.

(RTTNews) - Glenmark Pharmaceuticals Inc., USA (GLENMARK.NS), Thursday announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules.

Glenmark Pharmaceuticals on Tuesday, January 21, said its US arm has launched Phytonadione Injectable Emulsion USP, 10mg/ml ...

Glenmark launches phytonadione injectable emulsion USP, 10 mg/mL single dose ampules: Our Bureau, Mumbai Tuesday, January 21, 2025, 12:15 Hrs [IST] Glenmark Pharmaceuticals Inc., ...

Glenmark Pharmaceuticals added 1.32% to Rs 1524.05 after the company's US-based division Glenmark Pharmaceuticals Inc. announced the launch Phytonadione Injectable Emulsion.

Dr. Baas has served as a paid consultant or been on an Advisory Board for Hospira; Merck & Co., Inc.; Pfizer Inc. Dr. Vokes has received research funding from Bristol-Myers Squibb Company ...

The single-dose ampules is bioequivalent and therapeutically equivalent to the reference listed drug, Vitamin K1 Injectable Emulsion USP, 10 mg/mL of Hospira, Inc, the statement added.